About
Janet Wei, MD, FACC, is a cardiologist with the Barbra Streisand Women's Heart Center, Co-Director of the Stress Echocardiography Lab at the Cedars-Sinai Heart Institute, and Assistant Medical Director of the Biomedical Imaging Research Institute. Dr. Wei is board certified in internal medicine and cardiovascular diseases, and treats persistent chest pain, microvascular dysfunction, atherosclerosis, hypertension, high cholesterol, and heart failure. She is also board certified in echocardiography, nuclear cardiology, and cardiac computed tomography. Dr. Wei received her medical degree from Northwestern University and completed her internal medicine residency at Cedars-Sinai. She remained at Cedars-Sinai for her general cardiology fellowship and was a Chief Cardiology Fellow in 2012-2013. She completed an additional year of advanced training in women’s heart disease as the 2013-2014 Constance Austin Women’s Heart Fellow at the Barbra Streisand Women’s Heart Center. Dr. Wei’s research interests include heart disease in women, cardiovascular disease prevention, and coronary vascular dysfunction. Her research is National Institutes of Health (NIH) funded and includes the evaluation of coronary, carotid, and peripheral atherosclerosis using magnetic resonance imaging. She has published her research in peer-reviewed journals and presented at national cardiology conferences. She is the recipient of the American Heart Association Women in Cardiology Trainee Award for Excellence, the Cedars-Sinai Sports Spectacular Endowed Fellowship Award, and the American College of Cardiology (ACC) Emerging Faculty Award. Janet Wei, MD, FACC, FAHA is the Assistant Director of the Barbra Streisand Women's Heart Center, Associate Program Director of the Cardiology Fellowship Training Program, Co-Director of the Stress Echocardiography Lab, and Associate Medical Director of the Biomedical Imaging Research Institute at Cedars-Sinai Medical Center. Dr. Wei completed her internal medicine residency and cardiology fellowship at Cedars-Sinai Medical Center, which was followed by advanced clinical and research training in women’s heart disease as a National Institutes of Health (NIH) T32 Trainee at the Cedars-Sinai Smidt Heart Institute. Dr. Wei’s clinical and research interests include cardiovascular disease in women, preventive cardiology, coronary microvascular dysfunction and coronary vasospasm. Janet Wei, MD, FACC, FAHA is the Co-Director of the Stress Echocardiography Lab and Assistant Medical Director of the Biomedical Imaging Research Institute at Cedars-Sinai Medical Center. Dr. Wei completed her internal medicine residency and cardiology fellowship at Cedars-Sinai Medical Center, which was followed by advanced clinical and research training in women's heart disease as a National Institutes of Health (NIH) T32 Trainee at the Barbra Streisand Women's Heart Center. Dr. Wei is board certified in internal medicine and cardiovascular diseases, as well as echocardiography, nuclear cardiology, and cardiac computed tomography. Dr. Wei's clinical and research interests include cardiovascular disease in women, preventive cardiology, coronary vascular dysfunction, and advanced cardiovascular imaging. She is a co-investigator on several ongoing studies and clinical trials focusing on the diagnosis, prognosis, and management of patients with ischemia and no obstructive coronary arteries. Her research is NIH funded and includes the evaluation of coronary, carotid, and peripheral atherosclerosis using magnetic resonance imaging. She serves as a member of the American College of Cardiology Cardio-Obstetrics Work Group and the California Pregnancy-Associated Mortality Review committee and works closely with obstetricians in the cardiovascular care of pregnant and postpartum women.
View More >>Skills
Experience
Publication
-
February, 2022
Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries
Ischemic heart disease (IHD) is the leading cause of mortality in women. While traditional cardiovascular risk factors play an important role in the development of IHD in women, women may ex...
-
July, 2021
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial
Background Approximately half of all women with anginal symptoms and/or signs of ischemia and no obstructive coronary artery disease (INOCA) referred for coronary angiography have elevated ...
-
November, 2020
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructi...
Background: Myocardial infarction with nonobstructive coronary arteries (MINOCA) occurs in 6% to 15% of myocardial infarctions (MIs) and disproportionately affects women. Scientific stateme...
-
February, 2019
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
Background: Currently as many as one-half of women with suspected myocardial ischemia have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is commonly fo...
-
August, 2018
Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
An increasing number of stable patients with evidence of ischemia but no obstructive coronary artery disease (CAD) at coronary angiography, now termed INOCA, are seen. Objective myocardial i...
-
February, 2018
Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease
Cardiovascular disease (CVD) risk factors are well established. However, little is known about a woman’s cardiovascular response to pregnancy, which appears to be an early marker of future...
-
January, 2018
Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg...
A variety of observations suggest that coronary microvascular dysfunction (CMD) is related to the pathogenesis of cardiovascular disease, including myocardial ischaemia and heart failure.1,2...
-
September, 2017
Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol
Background Recent data from the National Cardiovascular Data Registry indicate that women with ST-segment-elevation myocardial infarction (STEMI) continue to have higher mortality and repor...
-
June, 2017
Coronary Atherosclerosis T1-Weighed Characterization With Integrated Anatomical Reference: Comparison With High-Risk Plaque Features Detected by Invas...
Objectives: The aim of this work is the development of coronary atherosclerosis T1-weighted characterization with integrated anatomical reference (CATCH) technique and the validation by com...
-
May, 2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Womenâ€...
Background Women with signs and symptoms of ischemia, no obstructive coronary artery disease (CAD) and preserved left ventricular ejection fraction (EF) often have diastolic dysfunction and...
Scholar9 Profile ID
S9-012025-1808541

Publication
(17)

Article Reviewed
(0)

Citations
(1766)

Network
(14)

Conferences/Seminar
(0)